Delnavaz Shahr, A., & Nasuhi Pur, F. (2019). Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker. Iran J Pharm Res.
Styl cytowania ChicagoDelnavaz Shahr, Amirali, i Fazel Nasuhi Pur. "Calixmexitil: Calixarene-based Cluster of Mexiletine With Amplified Anti-myotonic Activity As A Novel Use-dependent Sodium Channel Blocker." Iran J Pharm Res 2019.
Styl cytowania MLADelnavaz Shahr, Amirali, i Fazel Nasuhi Pur. "Calixmexitil: Calixarene-based Cluster of Mexiletine With Amplified Anti-myotonic Activity As A Novel Use-dependent Sodium Channel Blocker." Iran J Pharm Res 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..